| 1 |
Dobrek L, Głowacka K. Depression and Its Phytopharmacotherapy-A Narrative Review. Int J Mol Sci 2023;24. [PMID: 36902200 DOI: 10.3390/ijms24054772] [Reference Citation Analysis]
|
| 2 |
Mokhtari T, Yue LP, Hu L. Exogenous melatonin alleviates neuropathic pain-induced affective disorders by suppressing NF-κB/ NLRP3 pathway and apoptosis. Sci Rep 2023;13:2111. [PMID: 36747075 DOI: 10.1038/s41598-023-28418-1] [Reference Citation Analysis]
|
| 3 |
Lesicka M, Dmitrzak-Weglarz M, Jablonska E, Wieczorek E, Kapelski P, Szczepankiewicz A, Pawlak J, Reszka E. Methylation of melatonin receptors in patients with unipolar and bipolar depression. Mech Ageing Dev 2023;211:111776. [PMID: 36706965 DOI: 10.1016/j.mad.2023.111776] [Reference Citation Analysis]
|
| 4 |
Campos LA, Baltatu OC, Senar S, Ghimouz R, Alefishat E, Cipolla-Neto J. Multiplatform-Integrated Identification of Melatonin Targets for a Triad of Psychosocial-Sleep/Circadian-Cardiometabolic Disorders. Int J Mol Sci 2023;24. [PMID: 36614302 DOI: 10.3390/ijms24010860] [Reference Citation Analysis]
|
| 5 |
Zubkov E, Abramova O, Zorkina Y, Ochneva A, Ushakova V, Morozova A, Gurina O, Majouga A, Chekhonin V. Intranasal neuropeptide Y is most effective in some aspects of acute stress compared to melatonin, oxytocin and orexin. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1033186] [Reference Citation Analysis]
|
| 6 |
Iorio C, Pacitti F, Rossi A, Iorio P, Pompili A. Declarative Memory Impairment and Emotional Bias in Recurrent Depression with a Seasonal Pattern: The Interplay between Emotion and Cognition in Seasonal Affective Disorder. Brain Sci 2022;12. [PMID: 36291286 DOI: 10.3390/brainsci12101352] [Reference Citation Analysis]
|
| 7 |
Fraile-martinez O, Alvarez-mon MA, Garcia-montero C, Pekarek L, Guijarro LG, Lahera G, Saez MA, Monserrat J, Motogo D, Quintero J, Alvarez-mon M, Ortega MA. Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine. Front Oncol 2022;12:956923. [DOI: 10.3389/fonc.2022.956923] [Reference Citation Analysis]
|
| 8 |
Ahmad N, Khalid MS, Al Ramadhan AM, Alaradi MZ, Al Hammad MR, Ansari K, Alqurashi YD, Khan MF, Albassam AA, Ansari MJ, Akhtar S, Dilshad M. Preparation of melatonin novel-mucoadhesive nanoemulsion used in the treatment of depression. Polym Bull . [DOI: 10.1007/s00289-022-04436-3] [Reference Citation Analysis]
|
| 9 |
Mokhtari T, Yue L, Hu L. Exogenous melatonin alleviates neuropathic pain-induced affective disorders by suppressing NF-ᴋB/ NLRP3 pathway and apoptosis.. [DOI: 10.21203/rs.3.rs-1908807/v1] [Reference Citation Analysis]
|
| 10 |
Tancredi S, Urbano T, Vinceti M, Filippini T. Artificial light at night and risk of mental disorders: A systematic review. Sci Total Environ 2022;833:155185. [PMID: 35417728 DOI: 10.1016/j.scitotenv.2022.155185] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 11 |
Kholghi G, Eskandari M, Shokouhi Qare Saadlou MS, Zarrindast MR, Vaseghi S. Night shift hormone: How does melatonin affect depression? Physiol Behav 2022;252:113835. [PMID: 35504318 DOI: 10.1016/j.physbeh.2022.113835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Correia AS, Vale N. Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways. IJMS 2022;23:8493. [DOI: 10.3390/ijms23158493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 13 |
Zhong B, Xu Y, Li Y. Prevalence and Unmet Need for Mental Healthcare of Major Depressive Disorder in Community-Dwelling Chinese People Living With Vision Disability. Front Public Health 2022;10:900425. [DOI: 10.3389/fpubh.2022.900425] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Thurfah JN, Christine -, Bagaskhara PP, Alfian SD, Puspitasari IM. Dietary Supplementations and Depression. JMDH 2022;Volume 15:1121-41. [DOI: 10.2147/jmdh.s360029] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 15 |
Sato S, Bunney B, Mendoza-Viveros L, Bunney W, Borrelli E, Sassone-Corsi P, Orozco-Solis R. Rapid-acting antidepressants and the circadian clock. Neuropsychopharmacology 2022;47:805-16. [PMID: 34837078 DOI: 10.1038/s41386-021-01241-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 16 |
Hoseini SG, Heshmat-Ghahdarijani K, Khosrawi S, Garakyaraghi M, Shafie D, Mansourian M, Roohafza H, Azizi E, Sadeghi M. Melatonin supplementation improves N-terminal pro-B-type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trial. Clin Cardiol 2022. [PMID: 35170783 DOI: 10.1002/clc.23796] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Chen S, Zhong H, Mei G. Stable abnormalities of contrast discrimination sensitivity in subthreshold depression: A longitudinal study. Psych J 2022. [PMID: 35168295 DOI: 10.1002/pchj.525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Fernando J, Stochl J, Ersche KD. Drug Use in Night Owls May Increase the Risk for Mental Health Problems. Front Neurosci 2022;15:819566. [DOI: 10.3389/fnins.2021.819566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Litwack G. The pineal gland. Hormones 2022. [DOI: 10.1016/b978-0-323-90262-5.00023-8] [Reference Citation Analysis]
|
| 20 |
Won E, Na KS, Kim YK. Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression. Int J Mol Sci 2021;23:305. [PMID: 35008730 DOI: 10.3390/ijms23010305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 21 |
Wang YQ, Jiang YJ, Zou MS, Liu J, Zhao HQ, Wang YH. Antidepressant actions of melatonin and melatonin receptor agonist: Focus on pathophysiology and treatment. Behav Brain Res 2021;420:113724. [PMID: 34929236 DOI: 10.1016/j.bbr.2021.113724] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 22 |
Wang HQ, Liu HT, Wang L, Min L, Chen B, Li H. Uncovering the active components, prospective targets, and molecular mechanism of Baihe Zhimu decoction for treating depression using network pharmacology-based analysis. J Ethnopharmacol 2021;281:114586. [PMID: 34464700 DOI: 10.1016/j.jep.2021.114586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 23 |
Yardimci A, Ozdede MR, Kelestimur H. Agomelatine, A Potential Multi-Target Treatment Alternative for Insomnia, Depression, and Osteoporosis in Postmenopausal Women: A Hypothetical Model. Front Psychiatry 2021;12:654616. [PMID: 34267684 DOI: 10.3389/fpsyt.2021.654616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
